Investigation of m2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: evidence from bioinformatic and experiments

HIGHLIGHTS

• who: Zhen Zeng from the Nanjing Medical University, China have published the research work: Investigation of M2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: Evidence from bioinformatic and experiments, in the Journal: (JOURNAL)
• what: Next, the authors aimed to identify a prognosis signature based on the M2 macrophage-related gene to robustly predict the patients OS.
• how: The results showed that ABHD5 CAPZA2 LEPROT and MRO might be the risk factor of NSCLC while HS3ST2 TM6SF1 and HNMT might be the protective factors. Indicated that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.